In animals deoxynivalenol (DON) causes vomiting, feed refusal, growth retardation, and affects the immune system. DON is a common contaminant of wheat, however, validated biomarker data to assess exposure at the individual level and therefore any associated health effects are lacking. The development of a highly robust assay for urinary DON involving immunoaffinity (IAC) clean-up and liquid chromatography (LC)-mass spectrometric (MS) detection has allowed the assessment of (1) DON exposure within UK individuals and (2) a wheat intake intervention on urinary DON levels. Twenty-five volunteers from the United Kingdom (aged 21-59 years) completed semi-weighed food diaries on days 1 and 2 (normal diet), and a morning urine sample was provided on day 3. On days 3-6 (intervention), individuals restricted major sources of wheat intake following dietary guidance. Diaries were completed on days 5 and 6, and a further morning urine was provided on day 7. Urinary DON was measured following IAC clean-up and analysis by LC-MS. Wheat-based food intake (mean 322 g/day, range: 131-542 g/day), was significantly (Po0.001) reduced during the intervention to 26 g/day (range: 0-159 g/day) indicating good compliance. DON was detected in all 25 urine samples taken on day 3 (geometric mean 7.2 ng DON/mg creatinine (95% confidence interval (CI) 4.9-10.5 ng/mg), but following the intervention there was a significant 11-fold reduction (Po0.001) to 0.6 ng per mg (95% CI 0.4-0.9 ng/mg). These data are unique in demonstrating human exposure to DON in the United Kingdom using a urinary biomarker. Furthermore, the study demonstrates that exposure can be markedly reduced by avoiding wheat in the diet. On the basis of urinary biomarker levels some individuals are predicted to exceed current recommended daily intakes of DON, and thus the health consequences of these exposures merit further investigation.
Introduction
Diet-related ill health may be caused by imbalances in nutrient ingestion or by the presence of food contaminants, including fungal metabolites known as mycotoxins. Mycotoxins contaminate up to 25% of the world food supply (CAST, 2003) and many have potent biological effects. However, with some notable exceptions investigations of the human health effects of exposures to mycotoxins are limited (Wild and Hall, 1996) . Aflatoxins, for example, are known human liver carcinogens (IARC, 2002) and have more recently been associated with growth impairment in young children in West Africa (Gong et al., 2002 (Gong et al., , 2004 Turner et al., 2003 Turner et al., , 2007 . For aflatoxins, the development and use of urinary and blood-based exposure biomarkers has proved critical in understanding their role in human disease (Groopman and Kensler, 1999; Turner, 2001, 2002) . In more temperate climates, such as Europe and parts of North America, trichothecene mycotoxins, including, deoxynivalenol (DON) are common dietary contaminants. A recent survey of 44,670 foods, predominantly cereals, from European Union member states revealed a high frequency (57%) of cereal contamination by DON (SCOOP, 2003) . The European Commission Scientific Committee for Food recently established a tolerable daily intake (TDI) of 1000 ng/ kg (bw)/day for DON (SCF, 2002) . For the United Kingdom, average dietary intakes for DON were estimated in adults to be around 150 ng/kg (bw)/day in adults and somewhat higher at around 450 ng/kg (bw)/day in infants and young children (o6.0 years old). However, the expected ranges of exposures in both adults and children would suggest that some individuals will exceed the recommended TDI.
The toxicity of DON has been clearly established based on animal studies, and was recently reviewed with a view to understand the health risks caused by human exposures through diet (Pestka and Smolinski, 2005) . DON and other trichothecenes bind to the 60S ribosomal subunit which inhibits translation and activates a signalling pathway known as the ribotoxic stress response (Pestka and Smolinski, 2005) . DON ingestion causes acute gastrointestinal effects in animals including vomiting, feed refusal, and growth retardation (Pestka and Smolinski, 2005) . There are clear species differences in susceptibility, with swine and rodents being the most sensitive and poultry and ruminants the least. These variations may in part reflect species differences in intestinal detoxification to de-epoxy DON (Yoshizawa et al., 1986) . A recent small study examining faeces suggests that humans lack this putative detoxification route (SundstolEriksen and Pettersson, 2003) . Epidemiological data from food poisoning incidents in China between 1961 and 1991 imply that DON may have a role in acute human toxicity (Luo, 1994) . A food poisoning incident in 1987, affecting up to 50,000 individuals from the Kashmir Valley, India who consumed contaminated wheat (Bhat et al., 1989) lends further support to this hypothesis.
DON also has potent effects on the immune system (Bondy and Pestka, 2000; Meky et al., 2001) , including suppression of the normal immune response to pathogens. In addition DON-exposed mice exhibit elevation of serum IgAimmune complexes, mesangial IgA accumulation, and haematuria (reviewed by Pestka and Smolinski, 2005) . These are all hallmarks of IgA nephropathy (Berger's disease), the most common type of glomerulonephritis worldwide, which is of unknown aetiology. Increased levels of serum IgA have also been observed in DON-exposed swine (Goyarts et al., 2005; Tiemann et al., 2006) . In a recent review of human epidemiological data, the possibility of DON-induced gastroenteritis, growth faltering, and immunotoxicity with a possible increase in susceptibility to infectious disease was highlighted (Pestka and Smolinski, 2005) . Despite the information on food contamination and animal toxicology, there are no studies that have related individual human exposure to adverse health effects.
A major obstacle in studying DON and human health is the heterogeneous nature of cereal contamination, which makes the estimation of exposure at the individual level difficult. In response, the development of a urinary exposure biomarker was initiated based on immunoaffinity purification and liquid chromatography (LC)-mass spectrometric (MS) detection (Meky et al., 2003) . Using this approach, urinary DON was detected in a small study of Chinese subjects from Linxian County, Henan Province and Gejiu, and Yunnan Province (Meky et al., 2003) . To our knowledge this is the only reported biomarker assessment for exposure to DON. We report here further refinement of this urinary assay, by inclusion of 13 C-DON as an internal standard (IS). This highly robust assay has now been used to assess exposure within UK individuals. In the United Kingdom, wheat is the main cereal crop contaminated with DON (SCOOP, 2003) . On the basis of this knowledge firstly we examined whether urinary DON could be detected in the UK population and secondly, whether levels of urinary DON would be reduced by avoidance of wheat-based products in a short-term intervention study.
Methods

Study Design
The study took place over a 7-day period and involved 25 volunteers, 16 female and 9 male, aged 21-59 years. On days 1 and 2 (''normal diet'') semi-weighed food diaries were kept and on day 3 a first morning void urine sample was obtained. On days 3-6 (''reduced wheat intervention'') volunteers were requested to restrict intake of a specific list of food items likely to contain wheat (bread, cakes, pasta, breakfast cereal, etc.) and replace them with items from a list of suggested alternatives (e.g. rice, potatoes). On days 5 and 6 food diaries were again kept and a further first morning void urine sample was obtained on day 7. Informed consent was obtained from all volunteers prior to the study and ethical approval was obtained from the NHS Research Ethics Committee, Bradford, UK.
Food Diaries
Food diaries were fully coded using an in-house Microsoft Access based dietary analysis package, which uses the UK Composition of Foods (Holland et al., 1992) . To assess compliance with the intervention, the frequency of consumption of specific food groups (bread, cakes, breakfast cereals, and pasta) during normal diet (days 1 and 2) was compared to that during the intervention (days 5 and 6). In addition, the weights of specific food items were estimated and the intake of wheat-based foods was determined for each individual based on major sources of wheat (bread, breakfast cereals, rolls, pasta, cakes, and biscuits). Other sources of wheat do occur in the diet, such as in sauces and thickeners. However, their contribution to total wheat intakes was estimated to be of relatively minor importance.
Extraction of Urinary DON
Total urinary DON was measured using a modification of the method of Meky et al. (2003) and use of 13 C-DON (Biopure Referenzsubstanzen, Tulln, Austria) as an IS. The IS was a mixture containing predominantly 13 C 15 -DON (molecular mass (M r ) 311; 81.4%), but also 13 C 14 -DON (M r 310; 16.8%). The suitability of this compound as an IS in LC-MS/MS analysis of DON-contaminated cereals was recently established (Haubl et al., 2006) .
In our analysis of urine, samples were centrifuged (2000 g; 15 min; 41C) and to 4 ml of urine the IS was added to give a final concentration of 5 ng/ml. The pH of each sample was adjusted to 6.8, and 23,000 U of b-glucuronidase (Type IX-A from Escherichia coli; Sigma) in 1 ml 75 mM KH 2 PO 4 was added and incubated in a shaking water-bath for 18 h at 371C. Following digestion, the samples were centrifuged (2000 g; 15 min; 41C) and the supernatant was diluted to 16 ml with PBS (pH 7.2). The diluted material was passed through DONtest immunoaffinity columns (IACs) (Vicam, Watertown, MA, USA) to extract the DON according to the manufacturer's instructions. DON was eluted from columns with 4 ml of methanol and the extracts dried in vacuo using a Savant Speed Vac and reconstituted in 250 ml of 10% (v/v) ethanol for analysis. Two aliquots of a urine sample with known DON levels were also spiked with the IS and analysed with each batch of test samples as a quality control (QC).
LC-MS Analysis of Extracted DON
DON was analysed by HPLC (Waters 2795 separations module, Milford, MA, USA) with MS detection (Micromass Quattro Micro triple quadrupole mass spectrometer, Manchester, UK). Separation of DON was achieved using a Luna C18 column (150 Â 4.6 mm, 5 mm particle size (Phenomonex, Macclesfield, UK). The mobile phase was initiated at 20% methanol and ran isochratically for 10 min. A wash phase for 6 min was then conducted using 75% methanol, after which 20% methanol was reintroduced with equilibration of the system at this concentration for a further 11 min. The flow rate was 1 ml/min and injection volume was 25 ml. One-fifth of the eluant from the HPLC column was directed into the desolvation chamber of the MS and the remainder was sent to waste.
Selective ion recording was used to quantify DON by reference to the IS. The MS was used in positive ionisation mode and voltages of 3.5 kV, 350 V, 1 V, and 0.1 V were supplied to the capillary, cone, extractor, and RF lens, respectively. Cone temperature was set at 1001C and the desolvation temperature was set at 3001C. Nitrogen, purified from air by a nitrogen generator (Peak Scientific Instruments, Inchinnan, UK) acted as both cone and desolvation gases at flow rates of 50 and 500 l/h, respectively. Of the three masses produced for positively ionised DON, the Na Reduced urinary deoxynivalenol by wheat intervention Turner et al.
15 -DON were monitored for 0.25 s each and summed to produce one peak each for analyte and IS, see chromatograms in Figure 2 . External standards of concentrations 10, 20, 50, 100, and 200 ng/ml spiked with IS (80 ng/ml) were included at the start of each run and a further IS in the absence of unlabelled DON included at the end. Unknowns and QCs were quantified by reference to a response-ratio calibration curve generated by Quanlynx software. For the standard curve R 2 was 0.99. The limit of quantification (LOQ) in urine for this analysis was 0.6 ng DON/ml urine. The mean QC value was 10.4 ng/ml with a CV of 6.1%.
Creatinine Analysis
Creatinine concentrations were measured in all urine samples using the Bayer clinical method on an ADVIA Chemistry Systems 1650 instrument (Department of Clinical Biochemistry, Leeds General Infirmary, Leeds, UK). The final DON concentration in ng/ml of urine was adjusted using the creatinine data and was expressed as ng DON/mg creatinine.
Statistical Analysis
Where urinary DON was not quantifiable that is, below the LOQ, a mid-point value between the LOQ and zero was used in all analyses. Urinary DON concentrations were natural log transformed prior to analysis. Comparisons between paired data were made using Student's t-test, and regression analysis was applied to investigate the effect of age, sex, anthropometry, and food intake on urinary levels of DON both during the normal consumption and during the wheat reduction intervention (using STATA version 7.0). During the intervention period only, individuals were divided into consumers and non-consumers of major wheat-based food intake and the levels of urinary DON compared between groups using regression analysis in STATA. For ease of presentation, data for urinary DON were back transformed and geometric means and 95% confidence interval (CI) were used in tables.
Results
Demographic study data are provided in Table 1 . There were more females (n ¼ 16) than males (n ¼ 9). Females were both shorter (Po0.001) and weighed less (P ¼ 0.016) than males, although there was no difference in age or body mass index between the sexes.
During days 1 and 2 of the study individuals consumed their ''normal'' diet. The major food groups that were predicted to contribute to DON exposure (some breakfast cereals, bread, biscuits, cakes, and pasta) were consumed in amounts consistent with that reported previously for the UK population (Henderson et al., 2002) . All individuals consumed at least one of these food groups each day and 18 of 25 (72%) consumed two or more of these groups each day.
Overall bread was the most frequent source of wheat-based food with consumption by 20 of 25 individuals on day 1 and 22 of 25 on day 2 (see Table 2 ). Cakes and biscuits were consumed by 16 of 25 and 20 of 25 individuals with breakfast cereals and pasta being less frequently consumed ( Table 2) .
The intervention was implemented between days 3 and 6 and diary information was recorded to assess compliance with the suggested intervention on days 5 and 6. Overall there was good reported compliance with instructions to reduce the amount of wheat-based foods consumed. The reduction in the consumption of wheat-based food, both in terms of frequency of consumption and total amounts consumed is detailed in Table 2 . During the intervention only one person consumed bread on day 5 and two on day 6. No individuals consumed wheat-based breakfast cereals or pasta, while three and six individuals consumed cakes and biscuits on days 5 and 6, respectively. The reduction in the numbers of individuals consuming each of these food groups was highly significant, Po0.001 for each food group. For those individuals who continued to consume wheat-based items the quantities consumed were generally lower during the intervention compared to when they consumed their normal diet, although the one individual who consumed bread on days 5 and 6 slightly increased the quantity during this period compared to days 1 and 2.
To compensate for the reduction in consumption of major wheat-containing foods there was a significant increase (Po0.001) in the number of individuals consuming rice. During the period of normal diet, rice was eaten by 3 of 25 participants on each of days 1 and 2. This increased to 16 of 25 and 19 of 25 on days 5 and 6, respectively. Potato consumption increased (P ¼ 0.016) more modestly ( Table 2 ). The energy intake of individuals was highly variable with six individuals increasing and 19 individuals decreasing intake. However, complete maintenance of energy intake was not achieved by the study group as a whole with a mean change in energy intake of À13.4% (range: À57.7% to þ 47.6%).
Paired urinary samples were available from day 3, following 2 days of normal diet, and on day 7 following the 4-day intervention. During consumption of the normal diet, all individuals (25 of 25) had detectable urinary DON, whereas during the intervention fewer fell into this category (9 of 25; 36%). The levels of biomarker for each individual are shown in Figure 3 . The geometric mean level during normal diet (7.2 ng DON/mg creatinine; 95% CI 4.9-10.5 ng/mg) was 11-fold higher (Po0.001) than that during the intervention (0.6 ng/mg: 95% CI 0.4-0.9 ng/mg). The limited number of individuals and the relatively uniform consumption of major potential sources of DON in the normal diet phase of the study restricted an in-depth analysis of the contribution of specific foods to urinary DON levels. When compared to the period of normal diet, the intervention levels of urinary DON were reduced for 24 of 25 individuals. There was only one individual who did not comply with the suggested intervention. During the phase of normal diet this individual consumed wholemeal bread (average 131 g/day) as their major source of wheat. For this person, wholemeal bread remained the major source of wheat during the intervention and on days 5 and 6 the intake actually increased (average 154 g/day). This person was the one individual for whom the urinary DON level increased, from 5.2 ng/mg on day 3 to 12.6 ng/mg on day 7. Overall the average weight of wheat-based foods consumed during the normal diet (326 g; range: 40-665 g and 299 g; range: 0-523 g on days 1 and 2, respectively) was significantly lower (Po0.001) during the intervention (27 g; range: 0-157 g and 24 g; range: 0-176 g on days 5 and 6, respectively; see Table 3 ). These observations strongly suggest that reductions in the wheat-based food items gave rise to lower urinary DON levels in this study.
Discussion
DON is a common contaminant of wheat, barley, and maize cereal crops throughout the world, including Europe (Bondy and Pestka, 2000; SCOOP, 2003 ). The precise mechanisms by which DON may exert adverse effects on human health are unknown, but the toxin can bind to ribosomes disrupting protein synthesis, and additionally is able to activate important mitogen-activated protein kinases involved in signal transduction pathways (Pestka and Smolinski, 2005) . Gastroenteritis, growth faltering, and immunotoxicity, with a possible increase in susceptibility to infectious diseases have been suggested as the more likely affects of human intake of DON (Pestka and Smolinski, 2005) . However, to date the lack of a validated exposure biomarker has hampered our understanding of the consequences of DON exposure on health.
The current study is unique in demonstrating frequent human exposure to DON in the United Kingdom using a urinary biomarker and in demonstrating that exposure can be markedly reduced by limiting the amount of wheat in the diet. Notably, every individual in the study had detectable urinary DON when consuming his or her normal diet. DON contamination of barley and wheat used for beer production can provide an additional source of exposure (Papadopoulou-Bouraoui et al., 2004) although in our study beer was not part of the intervention. In addition, beer was only consumed on six occasions during the 4 days of diary collection (data not shown). The analysis involved the measurement of total Table 2 . Frequency of consumption and mean (g) intakes of dietary staples in 25 individuals consuming their normal diet (days 1 and 2) and during the wheat reduction intervention (days 5 and 6). Reduced urinary deoxynivalenol by wheat intervention Turner et al. urinary DON, that is, free DON and DON released from DON-glucuronide following enzyme treatment. The analytical approach is both sensitive and specific with purification by a highly selective antibody affinity column followed by reverse-phase chromatography and subsequent detection by MS. The recent availability of 13 C-DON as an IS has further improved the reliability of this assay.
The pharmacokinetics of human urinary excretion of DON and its metabolites has not been established. However, the glucuronide appears to be rapidly formed in swine and to have similar serum clearance kinetics to that of the parent compound (Goyarts and Danicke, 2006) . The pharmacokinetics of clearance of DON in both swine (Goyarts and Danicke, 2006) and rats (Meky et al., 2003) suggest that 4 days would be sufficient to excrete the majority of DON previously ingested once this mycotoxin was eliminated from the diet. The reduction in urinary levels following our 4-day intervention trial are consistent with that predicted for other urinary biomarkers for mycotoxins, where the marker generally reflects exposure over the previous 24-48 h due to a rapid excretion (Groopman et al., 1992) .
The recent SCOOP (2003) survey in the European Union highlighted the contamination of cereals and cereal products by DON and suggested that the TDI will be exceeded in some instances in the United Kingdom. However, there are many uncertainties in establishing human exposure to DON by food analysis and cereal intake estimates. First and foremost is the known heterogeneity of mycotoxin contamination of a given food commodity, making representative food sampling for analysis difficult to achieve. Second, exposure depends not only on contamination but also level of consumption. This can be determined from dietary surveys but may fail to account adequately for extremes of intake at the individual level or in specific subgroups within a population, for example, vegetarians and infants. The development of a urinary DON biomarker promises a more objective measure of exposure at the individual level. This approach has been successfully achieved with aflatoxins and has led to marked advances in understanding the exposure and the related health effects .
Using the urinary DON concentration in ng/ml of urine for each individual and the body weight (bw) of each individual it was possible to provide a crude estimate of intake. This estimate was based on studies derived from a rat model (Meky et al., 2003) and assumes (a) the concentration of DON in the morning urine sample is representative of the whole day; (b) excretion of 1.5 l of urine per day (Curhan et al., 2001; Van Haarst et al., 2004) ; (c) B35% of the ingested DON being excreted in the urine; and (d) that the urinary DON all originates from the previous 24 h intake only. Accordingly, for individuals consuming their normal diet the urinary levels observed (mean 10.7 ng DON/ml: range: 2.4-67.8 ng/ml) here translate to a mean intake of 729 ng/kg (bw)/day, a level that is of the same order of magnitude, although on the high side, as estimated in the 2003 SCOOP report for UK adults. In our small survey of 25 individuals, 4 would therefore be predicted to exceed the recommended TDI of 1000 ng/kg (bw)/day (SCF, 2002) . However, the caveats in this estimate, notably the assumed % of DON excreted in the urine in people, mean that the data should be interpreted with caution. If for example, 50% of the ingested DON were excreted as observed in swine (Goyarts and Danicke, 2006) then estimated intakes would be slightly lower. In a more global assessment, the Joint (FAO/WHO) Expert Committee on Food Additives (JECFA) estimated DON-dietary intakes using food consumption and contamination data (Canady et al., 2001) . Regions of the world were divided into five sections, European (which also includes Australia, Canada, US, and New Zealand), Latin America, Middle Eastern, Far Eastern, and African. Data for the estimates of exposure were often limited, particularly outside of Europe, although they do provide crude estimates of exposure internationally. The JECFA estimates are based on cereal consumers only, while it should be noted that the SCOOP data are for the population as a whole. The estimates range from a mean of 780 ng/kg (bw)/day in the African region (albeit based on data from South Africa alone) to 2400 ng/kg (bw)/day in the Middle Eastern diet, with the European region having an estimated intake of 1400 ng/kg (bw)/day. These alternative estimates suggest that globally the TDI for DON will be frequently exceeded. While the TDI is based on a ''No Observed Adverse Effect Level'' in animals and incorporates a safety factor, humans may be particularly sensitive to DON compared to animals (Sundstol-Eriksen and Pettersson, 2003) . These exposure observations therefore lend further support to the need for a wellvalidated biomarker with which to improve the understanding of both the level of exposure to DON and the associated health consequences of that exposure. This information would provide a firmer basis for future risk assessments for this mycotoxin.
Given the apparent common exposure and the potent toxicities exerted by DON in animals (Pestka and Smolinski, 2005) it is important that the potential health effects of the current levels of exposure in humans are investigated. Infants and children are predicted to have higher levels of intake compared to adults, and as with most toxic exposures the very young may be particularly susceptible. Other high-risk groups may include vegetarians, who consume particularly high levels of cereals. The availability of a biomarker of exposure makes such studies realistic for the first time.
